Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > 2 outta 3 ain't too bad, stay tuned.
View:
Post by itntdf on Apr 01, 2024 1:34pm

2 outta 3 ain't too bad, stay tuned.

(1) we know that andrew de g “left”

(2) we now know that oncy leased a new office in san diego

US Office

4350 Executive Drive

Suite 325

San Diego, CA 92121

(3) probably not safe to assume this space is being rented just to give people working from home an office address so that they can appear legitimate. Imagine next announcement will be a new obus head to replace the now departed andrew.

Last january I posted:

On Friday, January 5, 2024 at 02:34:38 PM EST, Matt Coffey wrote:

Thank you for your note.

-------------------------------

 

Concerning Andrew’s employment, the Company decided it wanted a different skill set for this role going forward. We are actively looking to fill this role at this point. As Andrew was not an officer of the Company, there are no requirements to announce his departure, and indeed we don’t announce non-officer departures. This is again due to these roles being non-material to the organization. As a Company policy, we all sign a non-disparaging agreement, so we do not provide any colour around a person’s leaving. If someone were to ask for a reference for any of our ex-employees, we typically only give the period that the organization employed them.

_________________

With respect to his LinkedIn account, the Company cannot compel employees to update their status. Within the industry, it is not uncommon for employees looking for work to not update their profile until they have secured a new role to prevent the appearance of gaps in their resumes.

________________

Regarding the California office, our lease expired, so we are moving to a new location about two blocks from the current office. Unlike the old office, this one is more work-friendly, bigger from a square footage perspective, and cheaper. Again, as this is a non-material, non-strategic event, we would not plan to announce moving offices within the same neighbourhood.

_____________________

I will speak with LSA about Tim’s apparently curt responses.

__________________

I have cc’ed Jon Patton should you wish to discuss any of these issues with him further.

________________

Regards,

Matt

________________

then cf posted:

 

Comment by canadafanon Jan 05, 2024 11:51pm

185 Views Post# 35813524

RE:shareholder interaction 101, note taking, not a doormat

That is a pile of artistic creativity.

You got ahold of Mstt how?

" diiffernt skill set" ....yet " can't discuss employees leaving"

Perhaps a fantasy of yours,

total none sense

Comment by inthno on Apr 01, 2024 3:41pm
How is it that Matt can say that Andrew was not an officer of the company when he was previously listed under managment and his picture used to be under leadership. This is from a recent investor presentation and I thought previously on the company website that he was listed as president of the San Diego office.... MANAGEMENT NON EXECUTIVE DIRECTORS SCIENTIFIC ADVISORY BOARD Matt Coffey, PhD, MBA ...more  
Comment by itntdf on Apr 01, 2024 4:07pm
my thought would be that andrew was heading up obus and obus was a subsidiary of oncolytics and as such, management of a subsidiary would not be considered as an officer or director of oncolytics biotech.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities